Ligand id: 6390
Name: apixaban
View more information in the IUPHAR Pharmacology Education Project: apixaban
|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2011), FDA (2012)) |
IUPAC Name ![]() |
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
8626 | apixaban |
Synonyms ![]() |
BMS-562247 | Eliquis® |
Comments |
Apixaban belongs to the direct factor Xa inhibitor family of drugs, which also includes rivaroxaban and edoxaban. |
Database Links ![]() |
|
CAS Registry No. | 503612-47-3 (source: PubChem) |
ChEBI | CHEBI:72296 |
ChEMBL Ligand | CHEMBL231779 |
DrugBank Ligand | DB06605 |
GtoPdb PubChem SID | 178103006 |
PubChem CID | 10182969 |
RCSB PDB Ligand | GG2 |
Search Google for chemical match using the InChIKey | QNZCBYKSOIHPEH-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | QNZCBYKSOIHPEH |
Search PubMed clinical trials | apixaban |
Search PubMed titles | apixaban |
Search PubMed titles/abstracts | apixaban |
Search UniChem for chemical match using the InChIKey | QNZCBYKSOIHPEH-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | QNZCBYKSOIHPEH |
SynPHARM | 78505 (in complex with coagulation factor X) |
Wikipedia | Apixaban |